Single Ascending Dose, Multiple Ascending Dose, Food Effect Study With AP31969
NCT06066099 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 92
Last updated 2025-07-14
Summary
The primary objective of the study is to evaluate the safety and tolerability of single doses (Part A) and multiple doses (Part B) of AP31969 in healthy participants.
Conditions
- Healthy Volunteers
Interventions
- DRUG
-
AP31969
Oral tablets
- DRUG
-
Oral tablets
Sponsors & Collaborators
-
Acesion Pharma
lead INDUSTRY
Principal Investigators
-
Director Clinical Operations · Acesion Pharma
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- DOUBLE
- Model
- SEQUENTIAL
Eligibility
- Min Age
- 18 Years
- Max Age
- 55 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-10-04
- Primary Completion
- 2025-03-14
- Completion
- 2025-03-14
Countries
- Netherlands
Study Locations
More Related Trials
-
A Study to Examine the Safety, Tolerability, and Pharmacokinetics of Single- and Multiple-ascending Doses of ACT-777991 in Healthy Subjects
NCT04798209 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Safety, Pharmacological Effect and Plasma Concentration of ASP7991 After Single Oral Administration to Healthy Volunteers
NCT01675518 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Investigate Safety and Tolerability Single Ascending Doses of AZD4017
NCT00791752 ·Status: COMPLETED ·Phase: PHASE1
-
First-in-Human, Single- and Multiple-Ascending Dose and Food-Effect Study of BGB-23339 in Healthy Participants
NCT05093270 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASP1617 in Healthy Adult Non-Asian and Japanese Subjects Including Assessment of a Food Effect
NCT04077879 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Safety, Tolerability, and Effects in and on the Body of Healthy Young and Elderly Male and Female Subjects of Ascending Multiple Oral Doses of ASP3652
NCT02243657 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics of AEB071
NCT00409929 ·Status: COMPLETED ·Phase: PHASE1
-
Dose Study of ANX1502 in Healthy Volunteers
NCT05521269 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Safety, Tolerability and Pharmacokinetics of ASP2205 in Healthy Young Males and Females and Elderly Females and to Evaluate the Effect of Food on the Pharmacokinetics of a Single Dose of of ASP2205
NCT02314793 ·Status: TERMINATED ·Phase: PHASE1
-
Study to Investigate the Safety, Tolerability and Activity of AZD5069 When Given as a Single Dose to Healthy Male and/or Female Subjects
NCT00953888 ·Status: COMPLETED ·Phase: PHASE1
-
A Clinical Study to See How the Study Drug MT-4129 is Taken up by the Body in Healthy Volunteers
NCT02953132 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Pharmacology Study of AZD7295 in Healthy Subjects
NCT00906256 ·Status: COMPLETED ·Phase: PHASE1
-
Single-Dose Safety Study of APD791 in Healthy Volunteers
NCT00529646 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ACT-389949 in Healthy Subjects
NCT02099201 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Safety, Tolerability and Effects of Single Ascending Doses of ASP3652 in Healthy Subjects
NCT01815684 ·Status: COMPLETED ·Phase: PHASE1
-
Single + Multiple Ascending Dose and Food Effect Study of AZD7986 in Healthy Volunteers, PK, PD and Safety Study
NCT02303574 ·Status: COMPLETED ·Phase: PHASE1
-
A First-in-human Study Looking at the Safety of ZP8396 and How it Works in the Body of Healthy Trial Participants
NCT05096598 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to See How Safe a New Medicine (NNC0705-0001) is in Healthy People
NCT07029568 ·Status: COMPLETED ·Phase: PHASE1
-
The Safety, Tolerability And Pharmacokinetics Of Single Ascending Doses And The Effect Of Food On Oral WCK 4873 In Healthy Adult Volunteers
NCT03926962 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Ascending Doses of ACT-1004-1239 in Healthy Male Subjects
NCT03869320 ·Status: COMPLETED ·Phase: PHASE1
-
CG400549 Single Ascending Dose Study
NCT01085578 ·Status: COMPLETED ·Phase: PHASE1
-
First in Men Study of Single Oral Doses of ASP1941 in Healthy Subjects
NCT01288885 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Food on the Pharmacokinetics of AQW051 in Japanese Healthy Male Subjects
NCT00409500 ·Status: COMPLETED ·Phase: PHASE1
-
A SAD, MAD and Food Effect Study to Evaluate the Safety, Tolerability, PK, and PD of AJA001 in Healthy Subjects
NCT06019065 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase 1 Study to Evaluate Safety and Tolerability of Single and Multiple Ascending Doses of XEN-101
NCT05667129 ·Status: COMPLETED ·Phase: PHASE1